Equity Long-Short

Mo Aziz

Capital markets veteran with 25 years across sell-side and buy-side research, investor relations, and fund management. Currently publish independent equity research (Mofferies Investment Research, via Smartkarma) spanning semiconductor memory (DRAM/NAND/HBM), foundry, semiconductor equipment and advanced packaging, gold and cross-asset strategy, financials forensics, and APAC IPOs — with a standing watchlist of 190+ companies across 41 countries. Background includes deep aviation-sector expertise (airlines, airports, OEMs, lessors, air cargo, travel/OTAs). Approach centers on identifying cyclical inflection points and mispriced risk across sectors, translated into explicit, actionable calls.

SEMICONDUCTOR MEMORY CYCLE MONITOR — Issue #9 | Special Thematic Edition | 3 Sep 2026

SEMICONDUCTOR MEMORY CYCLE MONITOR — Issue #10 | 30 Aug–4 Sep 2026

SEMICONDUCTOR MEMORY CYCLE MONITOR — Issue #11 | 5-12 Sep 2026

SEMICONDUCTOR MEMORY CYCLE MONITOR — Issue #6 | 9-15 Aug 2026

SEMICONDUCTOR MEMORY CYCLE MONITOR — Issue #7 | 15-21 Aug 2026

SEMICONDUCTOR MEMORY CYCLE MONITOR — Issue #5 | 1-8 Aug 2026

Thematic (Sector/Industry)

Macau Semiconductors and semiconductor equipment / Thematic (Sector/Industry)

<ul>
<li>NVIDIA's Q2 FY27 print is the cycle's strongest memory validation yet: supply commitments doubled to $279B — "primarily memory" — and the +70% FY28 guide is explicitly supply-capped.</li>
<li>The sector fell anyway. US/Korea/Japan resumed the slide on tariff threats and China risk; Taiwan alone rose on MSCI rebalancing flows. A multiple fight, not an earnings fight.</li>
<li>CXMT's maiden H1 filing (28 Aug) smashed guidance — RMB150.3bn revenue, RMB77.6bn profit. FV raised to RMB31.40; still −46% below spot. Take profit into strength.</li>
</ul>


NVIDIA's Q2 FY27 print is the cycle's strongest memory validation yet: supply commitments doubled to $279B — "primarily memory" — and the +70% FY28 guide is explicitly supply-capped.
The sector fell anyway. US/Korea/Japan resumed the slide on tariff threats and China risk; Taiwan alone rose on MSCI rebalancing flows. A multiple fight, not an earnings fight.
CXMT's maiden H1 filing (28 Aug) smashed guidance — RMB150.3bn revenue, RMB77.6bn profit. FV raised to RMB31.40; still −46% below spot. Take profit into strength.


SEMICONDUCTOR MEMORY CYCLE MONITOR — Issue #8 | 23-29 Aug 2026